This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Human normal immunoglobulin

Authoring team

Human normal immunoglobulin is extracted from the plasma of at least 1000 blood donors and it contains antibodies to common viral infections.

It is administered via intramuscular injection in the case of prophylaxis, but in some cases may be given intravenously.

Human normal immunoglobulin should not be administered less than 2 weeks after immunization with a live vaccine, and live vaccines should not be administered within 12 weeks of an immunoglobulin injection.

For further information, see BNF Section 14.5.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.